Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2276
Loma Negra
LOMA
$1.18B
| $1.65M | ﹤0.01% |
+387,762
| New | +$1.58M |
2020 Q2
0 quarters
|
|
2277
FB Financial Corp
FBK
$2.67B
| $1.65M | ﹤0.01% |
66,600
-42,700
| -39% | -$951K |
2017 Q1
13 quarters
|
|
2278
iShares Russell 1000 ETF
IWB
$49.7B
| $1.65M | ﹤0.01% |
9,600
-1,100
| -10% | -$178K |
2019 Q4
2 quarters
|
|
2279
Jakks Pacific
JAKK
$319M
| $1.65M | ﹤0.01% |
200,931
-16,774
| -8% | -$110K |
2014 Q4
22 quarters
|
|
2280
KKR & Co
KKR
$82B
| $1.65M | ﹤0.01% |
+53,350
| New | +$1.43M |
2020 Q2
0 quarters
|
|
2281
DELISTED
The L.S. Starrett Company
SCX
| $1.65M | ﹤0.01% |
485,915
+14,593
| +3% | +$49.7K |
2013 Q2
28 quarters
|
|
2282
Boise Cascade
BCC
$2.58B
| $1.64M | ﹤0.01% |
43,700
-83,600
| -66% | -$2.62M |
2018 Q3
7 quarters
|
|
2283
International Bancshares
IBOC
$4.26B
| $1.64M | ﹤0.01% |
51,337
-187,900
| -79% | -$5.4M |
2018 Q2
8 quarters
|
|
2284
Qfin Holdings
QFIN
$721M
| $1.64M | ﹤0.01% |
152,900
+110,704
| +262% | +$1.01M |
2019 Q4
2 quarters
|
|
2285
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.46B
| $1.64M | ﹤0.01% |
9,600
+6,000
| +167% | +$916K |
2020 Q1
1 quarter
|
|
2286
DELISTED
CONSTELLATION BRANDS, INC. CLASS B
STZ.B
| $1.64M | ﹤0.01% |
9,700
| – | – |
2014 Q1
25 quarters
|
|
2287
Dorian LPG
LPG
$2.5B
| $1.64M | ﹤0.01% |
211,222
-251,298
| -54% | -$2.08M |
2018 Q4
6 quarters
|
|
2288
Rein Therapeutics
RNTX
$66.7M
| $1.63M | ﹤0.01% |
69,194
+45,335
| +190% | +$739K |
2018 Q3
7 quarters
|
|
2289
Green Brick Partners
GRBK
$2.69B
| $1.63M | ﹤0.01% |
137,735
+60,000
| +77% | +$575K |
2019 Q3
3 quarters
|
|
2290
KT
KT
$8.63B
| $1.63M | ﹤0.01% |
167,500
-93,700
| -36% | -$893K |
2019 Q4
2 quarters
|
|
2291
aTyr Pharma
ATYR
$21.9M
| $1.62M | ﹤0.01% |
365,830
+156,830
| +75% | +$569K |
2016 Q3
15 quarters
|
|
|
BBQ
2292
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $1.62M | ﹤0.01% |
492,741
+4,500
| +0.9% | +$12.2K |
2013 Q2
28 quarters
|
|
2293
Fortress Biotech
FBIO
$70.7M
| $1.62M | ﹤0.01% |
40,267
+6,967
| +21% | +$259K |
2019 Q2
4 quarters
|
|
2294
DELISTED
Middlefield Banc Corp
MBCN
| $1.62M | ﹤0.01% |
77,940
-17,872
| -19% | -$331K |
2018 Q1
9 quarters
|
|
|
WRI
2295
DELISTED
Weingarten Realty Investors
WRI
| $1.62M | ﹤0.01% |
85,400
-910,919
| -91% | -$15.9M |
2019 Q1
5 quarters
|
|
2296
Castle Biosciences
CSTL
$999M
| $1.61M | ﹤0.01% |
42,836
+9,636
| +29% | +$329K |
2020 Q1
1 quarter
|
|
2297
First United
FUNC
$283M
| $1.61M | ﹤0.01% |
120,991
+7,490
| +7% | +$106K |
2019 Q1
5 quarters
|
|
2298
ProShares UltraPro Short QQQ
SQQQ
$2.11B
| $1.61M | ﹤0.01% |
+342
| New | +$2.41M |
2020 Q2
0 quarters
|
|
2299
Century Casinos
CNTY
$23.4M
| $1.61M | ﹤0.01% |
388,049
-483,117
| -55% | -$2.03M |
2013 Q2
28 quarters
|
|
2300
Corbus Pharmaceuticals
CRBP
$101M
| $1.61M | ﹤0.01% |
+6,387
| New | +$1.29M |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.